| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091507651 |
| P356 | DOI | 10.1186/S13046-017-0594-1 |
| P932 | PMC publication ID | 5591524 |
| P698 | PubMed publication ID | 28886730 |
| P2093 | author name string | Hao Liu | |
| Zhimin He | |||
| Xiaomin Feng | |||
| Zhijie Zhang | |||
| Yixue Gu | |||
| Huisi Qiu | |||
| P2860 | cites work | Control of cell cycle progression by c-Jun is p53 dependent | Q24607483 |
| Cancer treatment and survivorship statistics, 2012 | Q27020961 | ||
| The genetics of the p53 pathway, apoptosis and cancer therapy | Q27863460 | ||
| Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53 | Q28205515 | ||
| Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer | Q28393146 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer | Q29615476 | ||
| MAP kinase signalling pathways in cancer | Q29615542 | ||
| Cancer drug resistance: an evolving paradigm | Q29616694 | ||
| Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. | Q33284015 | ||
| Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells | Q33504768 | ||
| Diverse functions of JNK signaling and c-Jun in stress response and apoptosis | Q33771779 | ||
| Genotoxic agents promote the nuclear accumulation of annexin A2: role of annexin A2 in mitigating DNA damage | Q34505566 | ||
| Suppression of p53-dependent senescence by the JNK signal transduction pathway | Q34583257 | ||
| Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies. | Q34687047 | ||
| c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity | Q35005009 | ||
| Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis | Q35764336 | ||
| Chemoresistance in non-small cell lung cancer | Q36048311 | ||
| Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma | Q36053925 | ||
| Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells | Q36286180 | ||
| Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. | Q36294822 | ||
| Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer | Q36347121 | ||
| Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy | Q36433289 | ||
| Characterisation and protein expression profiling of annexins in colorectal cancer | Q36614738 | ||
| Annexin A2 heterotetramer: structure and function | Q36790362 | ||
| The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy | Q36971805 | ||
| Diagnosing and exploiting cancer's addiction to blocks in apoptosis | Q37059647 | ||
| Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis | Q37369869 | ||
| Anti-apoptotic mechanisms of drug resistance in cancer | Q37481512 | ||
| Signal integration by JNK and p38 MAPK pathways in cancer development | Q37560607 | ||
| Annexin A2: its molecular regulation and cellular expression in cancer development | Q37586765 | ||
| PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients | Q37680199 | ||
| RETRACTED ARTICLE: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy | Q37702749 | ||
| The role of annexin A2 in tumorigenesis and cancer progression | Q38366258 | ||
| Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation | Q38718020 | ||
| Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival | Q38768455 | ||
| ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. | Q38943647 | ||
| SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell | Q38963234 | ||
| Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway | Q38963460 | ||
| Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy | Q39890585 | ||
| Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor | Q42450037 | ||
| Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma | Q43632451 | ||
| Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma | Q44116010 | ||
| Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma | Q44157821 | ||
| The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair | Q44381511 | ||
| Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. | Q44737306 | ||
| c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. | Q53340770 | ||
| Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer | Q54159355 | ||
| Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells | Q57707735 | ||
| [The cloning and expression of apoptosis associated gene ANNEXIN A2 induced by p53 gene] | Q64378210 | ||
| Protein-binding elements in the promoter region of the mouse p53 gene | Q68565716 | ||
| Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers | Q72678324 | ||
| Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer | Q78709824 | ||
| Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas | Q80623290 | ||
| Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate | Q85422669 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 123 | |
| P577 | publication date | 2017-09-08 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells | |
| P478 | volume | 36 |
| Q93050799 | A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer |
| Q93109386 | Annexin A2 Expression in Aerogenous Metastasis of Pulmonary Invasive Mucinous Adenocarcinoma: A Case Report including Immunohistochemical Analysis |
| Q64237823 | Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs |
| Q92463707 | Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism |
| Q64239237 | DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53 |
| Q89909441 | FKBP51 induces p53-dependent apoptosis and enhances drug sensitivity of human non-small-cell lung cancer cells |
| Q97644729 | Ginsenoside Rh1 Alleviates HK-2 Apoptosis by Inhibiting ROS and the JNK/p53 Pathways |
| Q47731644 | Mst1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK/p53 pathway |
| Q64275561 | Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells |
| Q89658448 | Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity |
| Q95276455 | WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma |
| Q90132454 | miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma |
Search more.